Aak Ab · OMXSTO:AAK

Aak Ab — Investor Presentation (November 2016)

19 slides from Aak Ab's investor presentation, Nov 14, 2016

  1. Slide 1: Infant Nutrition

    Karel Stoschek BU President Infant Nutrition 14/11/2016

  2. Slide 2: Today’s agenda

    Today’s agenda 1 Global performance 2 Global market 3 Future direction 4 Key takeaways 22 The Co-Development Company

  3. Slide 3: Today’s agenda

    Today’s agenda 1 Global performance 2 Global market 3 Future direction 4 Key takeaways 33 The Co-Development Company

  4. Slide 4: Infant Nutrition – performance

    Infant Nutrition – performance Volume ('000 MT) Operating profit (SEK million) 100 250 200 80 150 60 100 40 50 20 0 2010 2012 2014 2016 2010 2012 2014 2016 Operating profit per kilo (SEK) 3,00 2,60 2,20 1,80 1,40 1,00 0,60 0,20 2010 2012 2014 2016 4 The Co-Development Company

  5. Slide 5: AAK Infant Nutrition at a glance

    AAK Infant Nutrition at a glance Global organization Sales Serving customers Marketing from 12 plants R&D around the world Product management Customer innovation AAK Sweden AAK China AAK Netherlands Q1, 2017 AAK UK AAK US AAK Mexico AAK Belgium AAK Turkey AAK Asia-Pacific AAK Brazil AAK Kamani 5 The

  6. Slide 6: Infant Nutrition – our value proposition to the industry

    Infant Nutrition – our value proposition to the industry  Growth in the current markets: INFAT is sold and marketed by Advanced Lipids*  US, Europe, India, China  Double-digit organic volume growth  Double-digit organic volume growth  New markets:  New customers and markets:  Pakistan, Iran,

  7. Slide 7: Today’s agenda

    Today’s agenda 1 Global performance 2 Global market 3 Future direction 4 Key takeaways 77 The Co-Development Company

  8. Slide 8: Trends driving growth

    Trends driving growth Sources: Euromonitor International, September 2016, World Bank & AAK 8 The Co-Development Company

  9. Slide 9: Attractive industry

    Attractive industry % of the category 62,5 B$ Special formula CAGR 9,7 % 7% (CAGR 6,5%) Premature, allergy 24,8 B$ Standard formula 29% (CAGR 7,9%) 0–6 months 2010 Milk formula global retail value US$ B 2020 Follow-on formula 21% (CAGR 8,7%) 6–12 months One of the fastest-growing packaged food categ

  10. Slide 10: China – the key market

    China – the key market CAGR 6,1 % Premium category growing 19M 16,65M E-commerce continuing to grow Regulatory changes in 2016 Customer consolidation Future birth rate growth 2015 Yearly birth rate in China 2019 Sources: China National Bureau of Statistics, September 2016 and AAK 10 The Co-Developme

  11. Slide 11: Today’s agenda

    Today’s agenda 1 Global performance 2 Global market 3 Future direction 4 Key takeaways 11 The Co-Development Company

  12. Slide 12: Importance of lipids in nutrition

    Importance of lipids in nutrition Lipids are essential nutrients and a vital energy source for healthy development throughout the human life. Brain development • Long-chain polyunsaturated fatty acids and brain health and phospholipids Bone strength • High omega 3 oils Reduced • High omega 3 oils in

  13. Slide 13: Expanding to wider special nutrition markets

    Expanding to wider special nutrition markets INFANT NUTRITION SENIOR NUTRITION MEDICAL NUTRITION New markets – New opportunities – New solutions 13 The Co-Development Company

  14. Slide 14: Expanding to wider special nutrition markets – Senior Nutrition

    Expanding to wider special nutrition markets – Senior Nutrition The elderly group in developed economies will grow from 164M in 2015 to 222M by 2030  35% The older consumers are increasingly focused on staying healthy for longer The 60+ age group has high spending power  60% of total urban cons

  15. Slide 15: Expanding to wider special nutrition markets – Medical Nutrition

    Expanding to wider special nutrition markets – Medical Nutrition  Growth market due to aging population, CAGR of 4,6% (2014–2021)  Parenteral nutrition, CAGR of 5,1%  Enteral nutrition, CAGR of 4,4%  Rising demand for health care services globally  Higher health care spending in emerging market

  16. Slide 16: Leverage a well-positioned business for future growth medium and long term

    Leverage a well-positioned business for future growth medium and long term End consumers have similar needs Go-To-Market synergies Tailor-made blends Sourcing special oils Regulatory and food safety 16 The Co-Development Company

  17. Slide 17: AAK capabilities for wider nutrition platform

    AAK capabilities for wider nutrition platform AAK has strong knowledge and a solid reputation within speciality oils and fats Global production footprint Global commercial and knowledgeable Customer Innovation team Customer Co-Development approach FDA approved facility (GMP, API) for medical nutriti

  18. Slide 18: Today’s agenda

    Today’s agenda 1 Global performance 2 Global market 3 Future direction 4 Key takeaways 18 The Co-Development Company

  19. Slide 19: Key takeaways – special nutrition

    Key takeaways – special nutrition Infant Nutrition – further growth One of the fastest-growing packaged food categories Global production footprint and Go-To-Market organization Tailor-made solutions to match customer needs Robust project pipeline Senior and Medical Nutrition – new growth areas Glob

AAK — Investor Presentation (November 2016) on 6ix